[New post] New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing

Editor posted: " Diagnostic Evaluations Were Consistent With Galleri®-Predicted Cancer Signal Origin in 78% of Study Participants Whole-Body Imaging Did Not Contribute to Diagnostic Resolution in More Than Half of Participants Results Were Presented at the 2023 " Concierge Medicine Today New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing Editor Jul 30 Diagnostic Evaluations Were Consistent With Galleri®-Predicted Cancer Signal Origin in 78% of Study Participants Whole-Body Imaging Did Not Contribute to Diagnostic Resolution in More Than Half of Participants Results Were Presented at the 2023 ASCO Annual Meeting MENLO PARK, Calif., June 3, 2023 — GRAIL, LLC, a healthcare company whose mission is to detect cancer early […] Read more of this post Unsubscribe to no longer receive posts from Concierge Medicine Today. Change your email settings at manage subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://conciergemedicinetoday.org/2023/07/30/new-pathfinder-study-analysis-demonstrates-efficient-diagnostic-resolution-following-multi-cancer-early-detection-testing-3/

Get the Jetpack app to use Reader anywhere, anytime Follow your favorite sites, save posts to read later, and get real-time notifications for likes and comments. Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110